The American Journal of Alzheimer's Disease and Other Dementias, published by SAGE Publications Inc, is a pivotal resource for researchers, clinicians, and students engaged in the study of neurodegenerative diseases, particularly Alzheimer’s disease and various forms of dementia. With an impact factor reflecting its significance in the field, the journal boasts an open-access format since 2020, ensuring that groundbreaking research is accessible to a global audience. The journal holds prestigious Q2 rankings across several categories, including Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Covering a wide spectrum from 1986 to 2024, it provides essential insights into innovative treatments, care strategies, and the latest findings in dementia research, solidifying its importance in fostering knowledge and advancing the field. With a commitment to high-quality scholarship, this journal is an indispensable tool for advancing understanding in the dynamic landscape of dementia studies.

EXPERIMENTAL GERONTOLOGY is a prestigious journal published by PERGAMON-ELSEVIER SCIENCE LTD, dedicated to the evolving field of aging research. With a rich history dating back to 1964 and continuing through 2024, this journal aims to advance the understanding of the biological processes underlying aging and develop interdisciplinary approaches to improve healthspan. ENCOMPASSING a broad scope, including *biochemistry*, *cell biology*, *endocrinology*, *genetics*, and *molecular biology*, it holds impressive rankings in the 2023 Scopus Ranks, featuring in Q1 and Q2 quartiles across multiple categories. This positions it as a vital resource for researchers and professionals focused on gerontology and related fields. As a subscription-based journal without open access, EXPERIMENTAL GERONTOLOGY ensures the dissemination of high-quality research through rigorous peer review, making it an essential publication for those aspiring to remain at the forefront of aging studies.

CEREBRAL CORTEX, published by Oxford University Press Inc, is a premier journal dedicated to advancing the field of neuroscience, specifically focusing on the cellular, molecular, and cognitive aspects of cortical structure and function. With an impressive impact factor that situates it in the top quartile (Q1) of its categories for 2023, this journal holds significant relevance for researchers and professionals interested in the latest discoveries and methodologies in both Cognitive Neuroscience (ranked #31 out of 115) and Cellular and Molecular Neuroscience (ranked #48 out of 97). Operating without an open access model, it ensures rigorous peer review and dissemination of high-quality research from across the globe. Since its inception in 1991, CEREBRAL CORTEX has established itself as a critical platform for educators and inventors, pushing the boundaries of knowledge in understanding brain function and its implications for behavior. Researchers and students alike will find this journal an invaluable resource for both foundational and cutting-edge studies in neuroscience.

METABOLIC BRAIN DISEASE, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal dedicated to advancing our understanding of the metabolic processes impacting brain health and disease. Established in 1986 and set to continue until 2024, this journal encompasses a wide range of interdisciplinary research that intersects the fields of Biochemistry, Cellular and Molecular Neuroscience, and Neurology, as evidenced by its notable quartile placements in Q2 and Q3 for 2023. With an ISSN of 0885-7490 and an E-ISSN of 1573-7365, it serves as a vital resource for researchers and practitioners aiming to deepen their insights into cerebral metabolic disorders and their implications. Although currently not an Open Access option, its rigorous peer-review process ensures that high-quality, impactful research reaches its audience. Showcasing a significant rank within the top percentile of its categories, METABOLIC BRAIN DISEASE is instrumental in shaping the future of neurological research and clinical applications.

Journal of Alzheimer's Disease, published by IOS Press, stands as a pivotal resource in the fight against Alzheimer's and related neurodegenerative disorders. With an ISSN of 1387-2877 and an E-ISSN of 1875-8908, this esteemed journal has evolved since its inception in 1998, providing a vital platform for academic research and clinical practice in the realms of Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Ranked in the Q1 category across several disciplines, including Clinical Psychology and Geriatrics, this journal not only highlights significant advancements in understanding Alzheimer's disease but also fosters interdisciplinary dialogue among researchers, healthcare professionals, and policymakers. Boasting robust Scopus rankings—such as 49th in Clinical Psychology and 29th in Geriatrics—this journal is committed to disseminating high-quality research that informs both therapeutic strategies and public health initiatives. The Journal of Alzheimer's Disease is an essential resource for anyone dedicated to exploring the complexities of cognitive decline and enhancing care for affected individuals.

NATURE NEUROSCIENCE is a premier journal published by NATURE PORTFOLIO, focusing on cutting-edge research in the field of neuroscience. With an esteemed impact factor that reflects its significance in the academic community, this journal occupies an exceptional place in the 2023 Q1 category for neuroscience (miscellaneous) and boasts a leading Scopus rank of #1 out of 113 in general neuroscience, placing it within the top 1st percentile. Since its inception in 1998, NATURE NEUROSCIENCE has consistently delivered high-quality, peer-reviewed articles that contribute to our understanding of the nervous system, driving innovation and scholarship across disciplines. Although it does not offer open access, the journal remains a vital resource for researchers, professionals, and students seeking to stay at the forefront of neuroscientific discovery and discussion. Its editorial commitment to excellence ensures that it continually shapes the trajectory of neuroscience research well into 2024 and beyond, making it an indispensable asset for anyone passionate about the brain and its complexities.

Frontiers in Aging is a leading academic journal published by FRONTIERS MEDIA SA, dedicated to advancing the understanding of the biological processes associated with aging. Established in 2020, this open-access journal aims to bridge the gap between various disciplines including genetics, molecular biology, and physiology, providing a multidisciplinary platform for researchers and clinicians alike. With a notable impact factor denoted by its Q2 quartile rankings in Aging, Genetics, and Molecular Biology, and a Q1 ranking in Physiology as of 2023, the journal is recognized for its contribution to the scientific community. Located in Lausanne, Switzerland, it is committed to promoting open discourse and publishing cutting-edge studies that address the complexities of aging and its implications for health and longevity. The journal’s editorial board, consisting of leading experts, ensures the rigorous peer-review process, maintaining high academic standards and fostering innovation in aging research.

NEUROREPORT is a distinguished journal in the field of neuroscience, published by Lippincott Williams & Wilkins. With an ISSN of 0959-4965 and an E-ISSN of 1473-558X, the journal has established itself as a vital platform for disseminating innovative research and developments in the dynamic area of neuroscience since its inception in 1990. Currently, it is positioned in the Q3 category of the 2023 Journal Rankings, reflecting its respectable standing within the community of neuroscience professionals, ranked #74 out of 113 in general neuroscience on Scopus, placing it in the 34th percentile. While it operates on a traditional subscription model, NEUROREPORT is committed to fostering knowledge sharing in the realm of neurobiology, neuropharmacology, and cognitive studies among researchers, professionals, and students alike. With its broad scope and commitment to scientific excellence, the journal continues to be a cornerstone for those seeking to stay ahead in the evolving landscape of neurological research.

AGING NEUROPSYCHOLOGY AND COGNITION, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, is a leading scholarly journal that spans the interdisciplinary fields of psychology, neuropsychology, and gerontology. With a strong focus on understanding aging processes and cognitive function, this journal serves as a critical platform for researchers, clinicians, and students dedicated to advancing knowledge in the realm of cognitive aging. The journal, established in 1994, presents high-quality research articles, comprehensive reviews, and innovative studies that contribute to the discourse surrounding mental health and aging. Notably, it has been recognized with a 2023 Q2 ranking in Experimental and Cognitive Psychology and Neuropsychology categories, reflecting its significant impact within these domains. The journal includes open access options, making it widely accessible to a global audience. Researchers interested in the latest findings and theoretical developments in aging neuropsychology will find this journal an invaluable resource, further enhanced by its robust Scopus rankings and commitment to academic excellence through 2024 and beyond.

BRAIN, published by Oxford University Press, stands as a preeminent journal in the realms of neurology and medicine, with a formidable impact factor reflecting its rigorous peer-reviewed standards and significant contributions to the field. With its ISSN 0006-8950 and E-ISSN 1460-2156, this esteemed publication spans over a century of exceptional research, converging from its historical roots in 1878 to current groundbreaking studies. BRAIN boasts a distinguished rank of #8 out of 400 in the Scopus category of Neurology (Clinical), placing it in the 98th percentile of institutions, indicative of its influence and reach. Operating under the Q1 category in both Medicine (Miscellaneous) and Clinical Neurology, the journal is dedicated to fostering interdisciplinary dialogue among researchers, clinicians, and students alike. With a focus on innovative findings and clinical advancements, BRAIN serves as a vital resource for those seeking to deepen their understanding of neurological disorders and the evolving landscape of medical research.